These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

471 related articles for article (PubMed ID: 37532073)

  • 21. Herbal medicines for fatty liver diseases.
    Liu ZL; Xie LZ; Zhu J; Li GQ; Grant SJ; Liu JP
    Cochrane Database Syst Rev; 2013 Aug; (8):CD009059. PubMed ID: 23975682
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Li-Gan-Shi-Liu-Ba-Wei-San improves non-alcoholic fatty liver disease through enhancing lipid oxidation and alleviating oxidation stress.
    Jiang Y; Chen L; Wang H; Narisi B; Chen B
    J Ethnopharmacol; 2015 Dec; 176():499-507. PubMed ID: 26571089
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tracking evidences of Coptis chinensis for the treatment of inflammatory bowel disease from pharmacological, pharmacokinetic to clinical studies.
    Yang Y; Vong CT; Zeng S; Gao C; Chen Z; Fu C; Wang S; Zou L; Wang A; Wang Y
    J Ethnopharmacol; 2021 Mar; 268():113573. PubMed ID: 33181286
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chinese Medicinal Herbs Targeting the Gut-Liver Axis and Adipose Tissue-Liver Axis for Non-Alcoholic Fatty Liver Disease Treatments: The Ancient Wisdom and Modern Science.
    Zhang S; Wong YT; Tang KY; Kwan HY; Su T
    Front Endocrinol (Lausanne); 2020; 11():572729. PubMed ID: 33101207
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current pharmacological therapies for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.
    Takahashi Y; Sugimoto K; Inui H; Fukusato T
    World J Gastroenterol; 2015 Apr; 21(13):3777-85. PubMed ID: 25852263
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mitochondrial structure and function: A new direction for the targeted treatment of chronic liver disease with Chinese herbal medicine.
    Yang Z; Wang J; Zhao T; Wang L; Liang T; Zheng Y
    J Ethnopharmacol; 2024 Nov; 334():118461. PubMed ID: 38908494
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Literature Review on the Use of Herbal Extracts in the Treatment of Non- Alcoholic Fatty Liver Disease.
    Wang Y; Wu J; Shi A
    Endocr Metab Immune Disord Drug Targets; 2022; 22(11):1123-1145. PubMed ID: 35400330
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identify Molecular Mechanisms of Jiangzhi Decoction on Nonalcoholic Fatty Liver Disease by Network Pharmacology Analysis and Experimental Validation.
    Wang L; Zhi Y; Ye Y; Zhang M; Ma X; Tie H; Ma X; Zheng N; Xia W; Song Y
    Biomed Res Int; 2020; 2020():8829346. PubMed ID: 33415161
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The mechanisms underlying Chinese medicines to treat inflammation in diabetic kidney disease.
    Deng L; Shi C; Li R; Zhang Y; Wang X; Cai G; Hong Q; Chen X
    J Ethnopharmacol; 2024 Oct; 333():118424. PubMed ID: 38844252
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prepared Radix Polygoni Multiflori and emodin alleviate lipid droplet accumulation in nonalcoholic fatty liver disease through MAPK signaling pathway inhibition.
    Huang C; Zhang Y; Xu Y; Wei S; Yang T; Wang S; Li C; Lin H; Li X; Zhao S; Zhu L; Pan W
    Aging (Albany NY); 2024 Jan; 16(3):2362-2384. PubMed ID: 38284886
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatoprotective effect of calculus bovis sativus on nonalcoholic fatty liver disease in mice by inhibiting oxidative stress and apoptosis of hepatocytes.
    He W; Xu Y; Zhang C; Lu J; Li J; Xiang D; Yang J; Chang M; Liu D
    Drug Des Devel Ther; 2017; 11():3449-3460. PubMed ID: 29255346
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Prevention and treatment of non-alcoholic fatty liver disease by regulation of mitochondrial function with Chinese medicine].
    Ma Q; Shi AH; Zhao X; Chen WL
    Zhongguo Zhong Yao Za Zhi; 2022 Oct; 47(19):5113-5120. PubMed ID: 36472018
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-ageing active ingredients from herbs and nutraceuticals used in traditional Chinese medicine: pharmacological mechanisms and implications for drug discovery.
    Shen CY; Jiang JG; Yang L; Wang DW; Zhu W
    Br J Pharmacol; 2017 Jun; 174(11):1395-1425. PubMed ID: 27659301
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Analysis on mechanisms and medication rules of herbal prescriptions for nonalcoholic fatty liver disease based on methods of data mining and biological information].
    Ding J; Zhang B; Wang PJ; He GN; Wei DM; Ding JL; Wang BC
    Zhongguo Zhong Yao Za Zhi; 2019 Apr; 44(8):1689-1695. PubMed ID: 31090336
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent progress on the application of compound formulas of traditional Chinese medicine in clinical trials and basic research in vivo for chronic liver disease.
    Xu F; Zhang H; Chen J; Zhan J; Liu P; Liu W; Qi S; Mu Y
    J Ethnopharmacol; 2024 Mar; 321():117514. PubMed ID: 38042388
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Traditional oriental medicine for sensorineural hearing loss: Can ethnopharmacology contribute to potential drug discovery?
    Castañeda R; Natarajan S; Jeong SY; Hong BN; Kang TH
    J Ethnopharmacol; 2019 Mar; 231():409-428. PubMed ID: 30439402
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison study of Beninese and Chinese herbal medicines in treating COVID-19.
    Houeze EA; Wang Y; Zhou Q; Zhang H; Wang X
    J Ethnopharmacol; 2023 May; 308():116172. PubMed ID: 36773790
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chinese herbal medicine mixture 919 syrup alleviates nonalcoholic fatty liver disease in rats by inhibiting the NF-κB pathway.
    Chen M; Xing J; Pan D; Peng X; Gao P
    Biomed Pharmacother; 2020 Aug; 128():110286. PubMed ID: 32521450
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Isobaric tags for relative and absolute quantitation (iTRAQ)-based proteomics for the investigation of the effect of Hugan Qingzhi on non-alcoholic fatty liver disease in rats.
    Yao X; Xia F; Tang W; Xiao C; Yang M; Zhou B
    J Ethnopharmacol; 2018 Feb; 212():208-215. PubMed ID: 29031784
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Natural products in traditional Chinese medicine: molecular mechanisms and therapeutic targets of renal fibrosis and state-of-the-art drug delivery systems.
    Song L; Zhang W; Tang SY; Luo SM; Xiong PY; Liu JY; Hu HC; Chen YQ; Jia B; Yan QH; Tang SQ; Huang W
    Biomed Pharmacother; 2024 Jan; 170():116039. PubMed ID: 38157643
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.